Veracyte, Inc. (VCYT) stock
VCYTNasdaqServices-Medical LaboratoriesFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 16/3034% below fair value
$24.23+0.22 (+0.92%)
Close on Nov 17, 2026Market cap $1.95BP/E 17.3Yield –
Veracyte cash
Cash and short-term investments held at the end of each period.
Veracyte's cash was $299.52M at Jun 30, 2026. For fiscal 2025 it was $412.89M, up 42.7% from the year before. Over ten years it grew 26.4% a year on average. The highest annual figure on record is $412.89M in fiscal 2025.
Annual cash
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $412.89M | +42.7% |
| FY2024 | Dec 31, 2024 | $289.40M | +33.7% |
| FY2023 | Dec 31, 2023 | $216.50M | +21.0% |
| FY2022 | Dec 31, 2022 | $178.90M | +2.8% |
| FY2021 | Dec 31, 2021 | $173.95M | -50.3% |
| FY2020 | Dec 31, 2020 | $349.97M | +118.8% |
| FY2019 | Dec 31, 2019 | $159.92M | +103.5% |
| FY2018 | Dec 31, 2018 | $78.60M | +127.9% |
| FY2017 | Dec 31, 2017 | $34.49M | -42.5% |
| FY2016 | Dec 31, 2016 | $59.94M | +50.6% |
| FY2015 | Dec 31, 2015 | $39.81M | +13.7% |
| FY2014 | Dec 31, 2014 | $35.01M | -50.8% |
| FY2013 | Dec 31, 2013 | $71.22M | +408.6% |
| FY2012 | Dec 31, 2012 | $14.00M | +85.1% |
| FY2011 | Dec 31, 2011 | $7.57M | +172.6% |
| FY2010 | Dec 31, 2010 | $2.78M | – |
Quarterly cash
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $299.52M | +35.4% |
| Q1 FY2026 | Mar 31, 2026 | $263.14M | +40.1% |
| Q4 FY2025 | Dec 31, 2025 | $412.89M | +42.7% |
| Q3 FY2025 | Sep 30, 2025 | $315.57M | +14.7% |
| Q2 FY2025 | Jun 30, 2025 | $221.15M | -6.7% |
| Q1 FY2025 | Mar 31, 2025 | $187.77M | -10.7% |
| Q4 FY2024 | Dec 31, 2024 | $289.40M | +33.7% |
| Q3 FY2024 | Sep 30, 2024 | $275.16M | +35.3% |
| Q2 FY2024 | Jun 30, 2024 | $237.00M | +23.4% |
| Q1 FY2024 | Mar 31, 2024 | $210.27M | +17.7% |
| Q4 FY2023 | Dec 31, 2023 | $216.50M | +21.0% |
| Q3 FY2023 | Sep 30, 2023 | $203.33M | +19.0% |
| Q2 FY2023 | Jun 30, 2023 | $192.03M | +24.5% |
| Q1 FY2023 | Mar 31, 2023 | $178.64M | +8.7% |
| Q4 FY2022 | Dec 31, 2022 | $178.90M | +2.8% |
| Q3 FY2022 | Sep 30, 2022 | $170.86M | +3.7% |
| Q2 FY2022 | Jun 30, 2022 | $154.20M | -53.0% |
| Q1 FY2022 | Mar 31, 2022 | $164.36M | -49.4% |
| Q4 FY2021 | Dec 31, 2021 | $173.95M | -50.3% |
| Q3 FY2021 | Sep 30, 2021 | $164.78M | -52.3% |
| Q2 FY2021 | Jun 30, 2021 | $328.29M | +121.7% |
| Q1 FY2021 | Mar 31, 2021 | $324.81M | +111.3% |
| Q4 FY2020 | Dec 31, 2020 | $349.97M | +118.8% |
| Q3 FY2020 | Sep 30, 2020 | $345.68M | +76.1% |
| Q2 FY2020 | Jun 30, 2020 | $148.05M | -23.4% |
| Q1 FY2020 | Mar 31, 2020 | $153.74M | +124.6% |
| Q4 FY2019 | Dec 31, 2019 | $159.92M | +103.5% |
| Q3 FY2019 | Sep 30, 2019 | $196.27M | +150.2% |
| Q2 FY2019 | Jun 30, 2019 | $193.25M | +693.3% |
| Q1 FY2019 | Mar 31, 2019 | $68.44M | +146.6% |
| Q4 FY2018 | Dec 31, 2018 | $78.60M | +127.9% |
| Q3 FY2018 | Sep 30, 2018 | $78.45M | +87.7% |
| Q2 FY2018 | Jun 30, 2018 | $24.36M | -48.4% |
| Q1 FY2018 | Mar 31, 2018 | $27.76M | -46.1% |
| Q4 FY2017 | Dec 31, 2017 | $34.49M | -42.5% |
| Q3 FY2017 | Sep 30, 2017 | $41.80M | +31.9% |
| Q2 FY2017 | Jun 30, 2017 | $47.19M | – |
| Q1 FY2017 | Mar 31, 2017 | $51.51M | – |
| Q4 FY2016 | Dec 31, 2016 | $59.94M | – |
| Q3 FY2016 | Sep 30, 2016 | $31.70M | – |
See a number that looks wrong?